Intended use:

For in-vitro diagnostics. This test is a lateral flow immunochromatographic assay for the quantitative detection of adalimumab (ADM, Humira®) in human serum and plasma.

General information:

The lateral flow assay RIDA®QUICK ADM Monitoring is a rapid assay, which allows for the quantitative determination of adalimumab trough levels (TLs) within 20 minutes. It facilitates the use of therapeutic drug monitoring (TDM) in hospitals and infusion centers and the decision making in regards to therapy adaptation.

  • Fast and reliable drug monitoring of adalimumab (Humira®)
  • Quantitative lateral flow test
  • 20 minutes time to result
  • High correlation to RIDASCREEN® ADM Monitoring due to identical monoclonal antibody (MA-ADM40D8)
  • 25 test cassettes per package
  • 2 controls available as accessory

Accessories:

Specifications
Art. No. GN3043
Standard range 0.5 - 25 µg/ml
Sample preparation In this assay, citrate plasma samples and serum samples can be used.
Incubation time 20 minutes
Files
InstructionsGerman
English
French
Italian
Spanish
SDSgn3043_german.zip (German)
gn3043_english.zip (English)
gn3043_french.zip (French)
gn3043_italian.zip (Italian)
gn3043_spanish.zip (Spanish)
Similar Products
RIDA®QUICK Helicobacter
RIDA®QUICK Helicobacter
For in vitro diagnostic use. RIDA®QUICK Helicobacter is an immunochromatographic rapid test (ICT) for the qualitative detection of Helicobacter pyl...
RIDA®QUICK ADM Monitoring Control Set
RIDA®QUICK ADM Monitoring C...
For in vitro diagnostic use. The RIDA®QUICK ADM Monitoring Control Set is intended for the use with the corresponding, batch specific kit RIDA®QUIC...
RIDA®QUICK ADM Monitoring
RIDA®QUICK ADM Monitoring
For in-vitro diagnostics. This test is a lateral flow immunochromatographic assay for the quantitative detection of adalimumab (ADM, Humira®) in hu...

Start typing and press Enter to search

gz3013-ridatube